Table 6.
System | ΔGBinding (kJ/mol) |
Electrostatic (kJ/mol) | Van der Waal (kJ/mol) | Polar Salvation (kJ/mol) | Non-Polar Salvation (kJ/mol) |
---|---|---|---|---|---|
EGFR-tak-285 | −68.33 ± 0.16 | −28.05 ± 0.16 | −50.93 ± 0.34 | 29.98 ± 0.27 | −11.33 ± 0.19 |
EGFR-lapatinib | −71.73 ± 0.24 | −13.74 ± 0.18 | −64.99 ± 0.31 | 25.59 ± 0.28 | −18.59 ± 0.14 |
EGFR-diosgenin | −67.65 ± 0.13 | −23.25 ± 0.33 | −54.92 ± 0.23 | 26.98 ± 0.31 | −16.46 ± 0.16 |
EGFR-monohydroxy spirostanol |
−62.73 ± 0.31 | −18.74 ± 0.34 | −53.99 ± 0.19 | 24.23 ± 0.30 | −14.23 ± 0.14 |
HER2-tak-285 | −72.08 ± 0.23 | −11.15 ± 0.26 | −69.93 ± 0.32 | 34.98 ± 0.23 | −25.98 ± 0.16 |
HER2-lapatinib | −80.24 ± 0.21 | −7.72 ± 0.22 | −78.99 ± 0.15 | 30.87 ± 0.19 | −24.40 ± 0.15 |
HER2-diosgenin | −78.85 ± 0.33 | −10.25 ± 0.16 | −72.68 ± 0.24 | 27.76 ± 0.24 | −23.68 ± 0.17 |
HER2-monohydroxy spirostanol | −69.31 ± 0.19 | −10.87 ± 0.18 | −65.36 ± 0.34 | 29.11 ± 0.28 | −22.19 ± 0.16 |